Focused on insuring medical providers and patients to have access to Genomic Health products and services by educating strategic market accounts on the value of Genomic Health Services. Earned support of customers as trusted business advisor which was accomplished by understanding critical success factors of customer and linking needs to needs of the patient and objectives of Genomic Health. Success evidenced by account stakeholders accepting and implementing those recommendations which in many cases was standardization of Oncotype Dx for early stage breast cancer patients. Developed contacts and relationships across account organizations and IDN’s including C-suite executives, Cancer Center Directors and identifying personnel who can influence change.